RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer

ObjectiveRNF180 (Ring finger protein 180) is an E3 ubiquitin-protein ligase that promotes polyubiquitination and proteasomal degradation. The study aimed to clarify the clinicopathological significances, signal pathways and molecular mechanisms of RNF180 expression in esophageal cancer.MethodsWe ana...

Full description

Saved in:
Bibliographic Details
Main Authors: Ning Li, Dao-Fu Shen, Nan-Chang Yin, Zheng-Guo Cui, Hua-Chuan Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1525431/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849710484178075648
author Ning Li
Dao-Fu Shen
Nan-Chang Yin
Zheng-Guo Cui
Hua-Chuan Zheng
author_facet Ning Li
Dao-Fu Shen
Nan-Chang Yin
Zheng-Guo Cui
Hua-Chuan Zheng
author_sort Ning Li
collection DOAJ
description ObjectiveRNF180 (Ring finger protein 180) is an E3 ubiquitin-protein ligase that promotes polyubiquitination and proteasomal degradation. The study aimed to clarify the clinicopathological significances, signal pathways and molecular mechanisms of RNF180 expression in esophageal cancer.MethodsWe analyzed the clinicopathological significances and signal pathways of RNF180 expression in esophageal cancer (EC) through bioinformatics and pathological analysis. We also clarified its effects on aggressiveness and related molecular mechanisms in vitro.ResultsRNF180 mRNA expression was lower in EC than in normal tissues (p < 0.05), opposite for its methylation (p < 0.05). RNF180 mRNA expression was negatively correlated with its promoter methylation, but positively with high histological grading, N stage, and poor prognosis of EC (p < 0.05). RNF180 protein expression was positively associated with T stage, N stage, and TNM stage, but negatively with unfavorable overall survival of EC as an independent factor (p < 0.05). The differential genes of RNF180 can be categorized into olfactory transduction, focal adhesion, vascular smooth muscle contraction, calcium signal pathway, cell adhesion molecules, muscle contraction, ECM receptor interaction, and collagen degradation (p < 0.05). RNF180-related genes can be categorized into gastric acid and insulin section, muscle and cardiomyopathy, glycoprotein binding, collagen and extracellular matrix, fat digestion and diabetes, PPAR signal pathway and peptidase activity. RNF180 overexpression reduced proliferation, migration, invasion and epithelial-mesenchymal transition, and induce mitochondrial apoptosis, and Caspase-1-dependent pyroptosis of EC cells (p < 0.05). RNF180 might induce chemosensitivity by weakening ACC1- and ACLY-mediated lipogenesis via the ubiquitination and proteasomal degradation of ACC1 and ACLY, and lipid droplet assembly.ConclusionRNF180 might be considered as a biological marker for aggressive behaviors and poor prognosis in EC and as a molecular target of gene therapy.
format Article
id doaj-art-aede1ceba2cc46c4a63c0635790e741f
institution DOAJ
issn 1663-9812
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-aede1ceba2cc46c4a63c0635790e741f2025-08-20T03:14:53ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-04-011610.3389/fphar.2025.15254311525431RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancerNing Li0Dao-Fu Shen1Nan-Chang Yin2Zheng-Guo Cui3Hua-Chuan Zheng4Center of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaDepartment of Clinical Laboratory, Chifeng Municipal Hospital, Chifeng, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaDepartment of Environmental Health, University of Fukui School of Medical Sciences, Fukui, JapanCenter of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaObjectiveRNF180 (Ring finger protein 180) is an E3 ubiquitin-protein ligase that promotes polyubiquitination and proteasomal degradation. The study aimed to clarify the clinicopathological significances, signal pathways and molecular mechanisms of RNF180 expression in esophageal cancer.MethodsWe analyzed the clinicopathological significances and signal pathways of RNF180 expression in esophageal cancer (EC) through bioinformatics and pathological analysis. We also clarified its effects on aggressiveness and related molecular mechanisms in vitro.ResultsRNF180 mRNA expression was lower in EC than in normal tissues (p < 0.05), opposite for its methylation (p < 0.05). RNF180 mRNA expression was negatively correlated with its promoter methylation, but positively with high histological grading, N stage, and poor prognosis of EC (p < 0.05). RNF180 protein expression was positively associated with T stage, N stage, and TNM stage, but negatively with unfavorable overall survival of EC as an independent factor (p < 0.05). The differential genes of RNF180 can be categorized into olfactory transduction, focal adhesion, vascular smooth muscle contraction, calcium signal pathway, cell adhesion molecules, muscle contraction, ECM receptor interaction, and collagen degradation (p < 0.05). RNF180-related genes can be categorized into gastric acid and insulin section, muscle and cardiomyopathy, glycoprotein binding, collagen and extracellular matrix, fat digestion and diabetes, PPAR signal pathway and peptidase activity. RNF180 overexpression reduced proliferation, migration, invasion and epithelial-mesenchymal transition, and induce mitochondrial apoptosis, and Caspase-1-dependent pyroptosis of EC cells (p < 0.05). RNF180 might induce chemosensitivity by weakening ACC1- and ACLY-mediated lipogenesis via the ubiquitination and proteasomal degradation of ACC1 and ACLY, and lipid droplet assembly.ConclusionRNF180 might be considered as a biological marker for aggressive behaviors and poor prognosis in EC and as a molecular target of gene therapy.https://www.frontiersin.org/articles/10.3389/fphar.2025.1525431/fullRNF180drug resistancelipid droplet formationaggressivenesstarget therapyesophageal cancer
spellingShingle Ning Li
Dao-Fu Shen
Nan-Chang Yin
Zheng-Guo Cui
Hua-Chuan Zheng
RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
Frontiers in Pharmacology
RNF180
drug resistance
lipid droplet formation
aggressiveness
target therapy
esophageal cancer
title RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
title_full RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
title_fullStr RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
title_full_unstemmed RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
title_short RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
title_sort rnf180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing acc1 and acly in esophageal cancer
topic RNF180
drug resistance
lipid droplet formation
aggressiveness
target therapy
esophageal cancer
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1525431/full
work_keys_str_mv AT ningli rnf180weakenedthelipiddropletformationandsubsequentchemoresistancebydestabilizingacc1andaclyinesophagealcancer
AT daofushen rnf180weakenedthelipiddropletformationandsubsequentchemoresistancebydestabilizingacc1andaclyinesophagealcancer
AT nanchangyin rnf180weakenedthelipiddropletformationandsubsequentchemoresistancebydestabilizingacc1andaclyinesophagealcancer
AT zhengguocui rnf180weakenedthelipiddropletformationandsubsequentchemoresistancebydestabilizingacc1andaclyinesophagealcancer
AT huachuanzheng rnf180weakenedthelipiddropletformationandsubsequentchemoresistancebydestabilizingacc1andaclyinesophagealcancer